Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
LORazepam
LORazepam
Brand names: Ativan
| Form | Strength |
|---|---|
| CONCENTRATE, ORAL | 2 mg/mL |
| SOLUTION, INJECTABLE | 2 mg/mL; 4 mg/mL |
| SOLUTION, INTRAVENOUS | 1 mg/mL-D5% |
| TABLET, ORAL | 0.5 mg; 1 mg; 2 mg |
Last updated: May. 16, 2023
- High Alert: CAUTION: See High-Alert Medication Policy
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
- Black Box Warning: Risk From Concomitant Use With Opioids
Class IV
or stopping medication
Acute Alcohol Withdrawal Protocol: See Protocol 900.6509
Use in a ventilated Critical Care patient: See 901.5008
For pediatric long term sedation weaning: See Protocol 912.6016
Use in mechanically ventilated patients, See the Pain, Agitation and Delirium Protocol (aka "PAD") Protocol 901.6008
Status Epilepticus Protocol for Adult Patients: See Protocol 900.6016
If extravasation occurs, please refer to Elsevier Clinical Skills: Prevention and Management of Extravasations for the Treatment and Management of Extravasations
General Titration Ranges and Administration (weight based dosing): See Handout (updated Aug 2016)